Engrail Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 18, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $32,000,000
Company Info
- Founding Year
- 2019
- Company Description
- Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
- Market
- Nervous System Diseases
- Location
- San Diego, CA, USA
- Coinvestors
- Nan Fung Life Sciences